相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progesterone Antagonist Therapy in a Pelizaeus-Merzbacher Mouse Model
Thomas Prukop et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Activation of NADPH oxidase subunit NCF4 induces ROS-mediated EMT signaling in HeLa cells
Young Mee Kim et al.
CELLULAR SIGNALLING (2014)
Cancer genetics and genomics of human FOX family genes
Masuko Katoh et al.
CANCER LETTERS (2013)
FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis
R. van Boxtel et al.
CELL DEATH AND DIFFERENTIATION (2013)
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
Antje Krohn et al.
JOURNAL OF PATHOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
H. Kocak et al.
CELL DEATH & DISEASE (2013)
FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma
Dan Li et al.
ONCOTARGET (2013)
Forkhead box proteins: tuning forks for transcriptional harmony
Eric W. -F. Lam et al.
NATURE REVIEWS CANCER (2013)
Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease
Bin Tang et al.
HUMAN MOLECULAR GENETICS (2012)
Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma
Yixin Zhang et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
E. E. Santo et al.
ONCOGENE (2012)
Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation
Yunhong Zha et al.
PLOS ONE (2012)
Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
Vanessa J. Craig et al.
BLOOD (2011)
HOXC9 Links Cell-Cycle Exit and Neuronal Differentiation and Is a Prognostic Marker in Neuroblastoma
Ling Mao et al.
CANCER RESEARCH (2011)
FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors
Zebin Wang et al.
CANCER RESEARCH (2011)
An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming
Mathieu Gabut et al.
CELL (2011)
Polo-Like Kinase 1 is a Therapeutic Target in High-Risk Neuroblastoma
Sandra Ackermann et al.
CLINICAL CANCER RESEARCH (2011)
Forkhead transcription factors: key players in health and disease
Berenice A. Benayoun et al.
TRENDS IN GENETICS (2011)
Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma
Yun-Sook Kim et al.
BMC CANCER (2010)
Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q-Neuroblastoma
Patrick G. Buckley et al.
CLINICAL CANCER RESEARCH (2010)
FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1
Sylvia Hoeller et al.
HISTOPATHOLOGY (2010)
MicroRNA-34a Perturbs B Lymphocyte Development by Repressing the Forkhead Box Transcription Factor Foxp1
Dinesh S. Rao et al.
IMMUNITY (2010)
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
Malcolm A. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Aldosterone: effects on the kidney and cardiovascular system
Marie Briet et al.
NATURE REVIEWS NEPHROLOGY (2010)
Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q
M. Fischer et al.
ONCOGENE (2010)
Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients
A. Oberthuer et al.
PHARMACOGENOMICS JOURNAL (2010)
Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma
Paola Scaruffi et al.
BMC CANCER (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Repression of BIRC5/Survivin by FOXO3/FKHRL1 Sensitizes Human Neuroblastoma Cells to DNA Damage-induced Apoptosis
Petra Obexer et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
The evolution of Fox genes and their role in development and disease
Sridhar Hannenhalli et al.
NATURE REVIEWS GENETICS (2009)
Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis
Jharna Datta et al.
CANCER RESEARCH (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor beta in primary invasive breast carcinomas
Gaynor J. Bates et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization
Paola Scaruffi et al.
CANCER GENETICS AND CYTOGENETICS (2007)
FOXP1: a potential therapeutic target in cancer
Henry B. Koon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
Aparna Raval et al.
CELL (2007)
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
Laurence Lamant et al.
BLOOD (2007)
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome
Ruediger Spitz et al.
GENES CHROMOSOMES & CANCER (2006)
Customized oligonucleotide microarray gene expression based classification of neuroblastoma patients outperforms current clinical risk stratification
Andre Oberthuer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Identification of potential human oncogenes by mapping the common viral integration sites in avian nephroblastoma
P Pajer et al.
CANCER RESEARCH (2006)
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry
M Ehrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations
I Wlodarska et al.
LEUKEMIA (2005)
Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma
MH Soltani et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation
B Wang et al.
DEVELOPMENT (2004)
Neuroblastoma: biology and molecular and chromosomal pathology
M Schwab et al.
LANCET ONCOLOGY (2003)
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
AM Verhagen et al.
CELL (2000)
分享论文
